Skip to main content
Equibles

BOOTHBAY FUND MANAGEMENT, LLC

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1549230 NEW YORK, NY
Back to KPTI Full portfolio

Position in KPTI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,190,921
+$126,459 QoQ
Shares Held
213,810
+47.8% QoQ
Ownership
0.943%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Derivatives in KPTI

reported options exposure · as of Mar 31, 2026
CallValue
$1,494,431
CallShares
268,300
PutValue
$1,494,431
PutShares
268,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 465,787 $87,232,589
2 ABVX
Abivax S.A.
 563,367 $75,074,286
3 EXEL
Exelixis, Inc.
 804,095 $43,750,808
4 PCVX
Vaxcyte, Inc.
 534,163 $31,050,895
5 COGT
Cogent Biosciences, Inc.
 692,825 $26,812,327
6 CGEM
Cullinan Therapeutics, Inc.
 1,082,611 $19,714,346
7 TNGX
Tango Therapeutics, Inc.
 500,497 $15,645,536
8 AVTX
Avalo Therapeutics, Inc.
 702,051 $12,973,902

All Filings in KPTI

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,190,921 213,810
2026-03-31 $1,494,431 268,300
2026-03-31 $1,494,431 268,300
2025-12-31 $1,064,462 144,628
2024-12-31 $61,269 90,635
2024-09-30 $75,605 91,091
2024-06-30 $79,066 91,091
2024-03-31 $137,547 91,091
2023-12-31 $70,701 81,736
2023-09-30 $109,526 81,736
2023-06-30 $146,307 81,736
2023-03-31 $238,884 61,410
2021-09-30 $230,600 39,622
2021-06-30 $238,051 23,067